Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Nanobiotechnology ; 22(1): 321, 2024 Jun 08.
Artigo em Inglês | MEDLINE | ID: mdl-38849841

RESUMO

Acute lung injury (ALI) is a life threatening disease in critically ill patients, and characterized by excessive reactive oxygen species (ROS) and inflammatory factors levels in the lung. Multiple evidences suggest that nanozyme with diversified catalytic capabilities plays a vital role in this fatal lung injury. At present, we developed a novel class of polydopamine (PDA) coated cerium dioxide (CeO2) nanozyme (Ce@P) that acts as the potent ROS scavenger for scavenging intracellular ROS and suppressing inflammatory responses against ALI. Herein, we aimed to identify that Ce@P combining with NIR irradiation could further strengthen its ROS scavenging capacity. Specifically, NIR triggered Ce@P exhibited the most potent antioxidant and anti-inflammatory behaviors in lipopolysaccharide (LPS) induced macrophages through decreasing the intracellular ROS levels, down-regulating the levels of TNF-α, IL-1ß and IL-6, up-regulating the level of antioxidant cytokine (SOD-2), inducing M2 directional polarization (CD206 up-regulation), and increasing the expression level of HSP70. Besides, we performed intravenous (IV) injection of Ce@P in LPS induced ALI rat model, and found that it significantly accumulated in the lung tissue for 6 h after injection. It was also observed that Ce@P + NIR presented the superior behaviors of decreasing lung inflammation, alleviating diffuse alveolar damage, as well as promoting lung tissue repair. All in all, it has developed the strategy of using Ce@P combining with NIR irradiation for the synergistic enhanced treatment of ALI, which can serve as a promising therapeutic strategy for the clinical treatment of ROS derived diseases as well.


Assuntos
Lesão Pulmonar Aguda , Cério , Indóis , Polímeros , Espécies Reativas de Oxigênio , Cério/química , Cério/farmacologia , Animais , Lesão Pulmonar Aguda/tratamento farmacológico , Polímeros/química , Polímeros/farmacologia , Indóis/química , Indóis/farmacologia , Espécies Reativas de Oxigênio/metabolismo , Ratos , Camundongos , Masculino , Células RAW 264.7 , Pulmão/efeitos dos fármacos , Pulmão/patologia , Antioxidantes/farmacologia , Antioxidantes/química , Ratos Sprague-Dawley , Lipopolissacarídeos/farmacologia , Anti-Inflamatórios/farmacologia , Anti-Inflamatórios/química , Raios Infravermelhos , Sequestradores de Radicais Livres/farmacologia , Sequestradores de Radicais Livres/química , Sequestradores de Radicais Livres/uso terapêutico , Nanopartículas/química , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Citocinas/metabolismo
2.
Food Res Int ; 100(Pt 1): 579-585, 2017 10.
Artigo em Inglês | MEDLINE | ID: mdl-28873724

RESUMO

Hypertension had relation to angiotensin I converting enzyme (ACE) activity and inflammation. In our previous research, sardine peptides (SP) with ACE inhibitory activity were prepared. However, the combinative effect of SP and quercetin (QC) on hypertension alleviation was still unknown. In the present study, the antihypertensive effect of SP and QC was discovered and the optimal proportion of SP and QC (v/v=8:2, with 20.00mg/mL of SP and 12.99µg/mL of QC for their original concentrations) was screened on ACE activity inhibition in vitro. And the in vivo experiment supported it by indicating that the mixture reduced the systolic blood pressure, heart, left ventricular and kidney weight and their corresponding indices, serum ACE activity, angiotensin-II (ANG-II) and tumor necrosis factor-α (TNF-α) (in high dose) concentration in SHR rats. Besides, the mixture also lowers NO, TNF-α andinterleukin-6 (IL-6) concentration significantly in vitro. Hence, the combinative effect of SP and QC in optimal proportion had stronger inhibition on ACE activity than SP or QC alone, and could alleviate hypertension through inhibition of ACE activity and inflammation.


Assuntos
Inibidores da Enzima Conversora de Angiotensina , Anti-Hipertensivos , Proteínas de Peixes , Peptídeos , Quercetina , Inibidores da Enzima Conversora de Angiotensina/química , Inibidores da Enzima Conversora de Angiotensina/farmacologia , Animais , Anti-Hipertensivos/química , Anti-Hipertensivos/farmacologia , Peso Corporal/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Citocinas/metabolismo , Proteínas de Peixes/química , Proteínas de Peixes/farmacologia , Inflamação/metabolismo , Masculino , Camundongos , Peptídeos/química , Peptídeos/farmacologia , Quercetina/química , Quercetina/farmacologia , Células RAW 264.7 , Ratos , Ratos Endogâmicos SHR , Ratos Endogâmicos WKY
3.
J Food Sci ; 81(9): H2273-9, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27472307

RESUMO

The impact of flavonoids has been discussed on the relative viability of bacterial groups in human microbiota. This study was aimed to compare the modulation of various flavonoids, including quercetin, catechin and puerarin, on gut microbiota culture in vitro, and analyze the interactions between bacterial species using fructo-oligosaccharide (FOS) as carbon source under the stress of flavonoids. Three plant flavonoids, quercetin, catechin, and puerarin, were added into multispecies culture to ferment for 24 h, respectively. The bacterial 16S rDNA amplicons were sequenced, and the composition of microbiota community was analyzed. The results revealed that the tested flavonoids, quercetin, catechin, and puerarin, presented different activities of regulating gut microbiota; flavonoid aglycones, but not glycosides, may inhibit growth of certain species. Quercetin and catechin shaped unique biological webs. Bifidobacterium spp. was the center of the biological web constructed in this study.


Assuntos
Bifidobacterium/efeitos dos fármacos , Catequina/farmacologia , Flavonoides/farmacologia , Microbioma Gastrointestinal/efeitos dos fármacos , Isoflavonas/farmacologia , Extratos Vegetais/farmacologia , Quercetina/farmacologia , Bifidobacterium/genética , Bifidobacterium/crescimento & desenvolvimento , Glicosídeos/farmacologia , Humanos , Microbiota , Oligossacarídeos , RNA Ribossômico 16S
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA